IBDEI18U ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,22039,0)
 ;;=90656^^124^1382^2^^^^1
 ;;^UTILITY(U,$J,358.3,22039,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,22039,1,2,0)
 ;;=2^FLU VACC SGLE DOSE SYR (AFLURIA)
 ;;^UTILITY(U,$J,358.3,22039,1,3,0)
 ;;=3^90656
 ;;^UTILITY(U,$J,358.3,22040,0)
 ;;=90662^^124^1382^1^^^^1
 ;;^UTILITY(U,$J,358.3,22040,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,22040,1,2,0)
 ;;=2^FLU VACC HIGH DOSE SYR (FLUZONE)
 ;;^UTILITY(U,$J,358.3,22040,1,3,0)
 ;;=3^90662
 ;;^UTILITY(U,$J,358.3,22041,0)
 ;;=90736^^124^1382^11^^^^1
 ;;^UTILITY(U,$J,358.3,22041,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,22041,1,2,0)
 ;;=2^ZOSTER (SHINGLES) VACCINE
 ;;^UTILITY(U,$J,358.3,22041,1,3,0)
 ;;=3^90736
 ;;^UTILITY(U,$J,358.3,22042,0)
 ;;=90670^^124^1382^8^^^^1
 ;;^UTILITY(U,$J,358.3,22042,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,22042,1,2,0)
 ;;=2^PNEUMOVAX 13 VALENT (PREVNAR)
 ;;^UTILITY(U,$J,358.3,22042,1,3,0)
 ;;=3^90670
 ;;^UTILITY(U,$J,358.3,22043,0)
 ;;=99420^^124^1383^1^^^^1
 ;;^UTILITY(U,$J,358.3,22043,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,22043,1,2,0)
 ;;=2^HEALTH RISK ASSESSMENT TEST
 ;;^UTILITY(U,$J,358.3,22043,1,3,0)
 ;;=3^99420
 ;;^UTILITY(U,$J,358.3,22044,0)
 ;;=86485^^124^1384^1^^^^1
 ;;^UTILITY(U,$J,358.3,22044,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,22044,1,2,0)
 ;;=2^CANDIDA
 ;;^UTILITY(U,$J,358.3,22044,1,3,0)
 ;;=3^86485
 ;;^UTILITY(U,$J,358.3,22045,0)
 ;;=86486^^124^1384^4^^^^1
 ;;^UTILITY(U,$J,358.3,22045,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,22045,1,2,0)
 ;;=2^MUMPS
 ;;^UTILITY(U,$J,358.3,22045,1,3,0)
 ;;=3^86486
 ;;^UTILITY(U,$J,358.3,22046,0)
 ;;=86580^^124^1384^5^^^^1
 ;;^UTILITY(U,$J,358.3,22046,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,22046,1,2,0)
 ;;=2^TB
 ;;^UTILITY(U,$J,358.3,22046,1,3,0)
 ;;=3^86580
 ;;^UTILITY(U,$J,358.3,22047,0)
 ;;=95024^^124^1384^3^^^^1
 ;;^UTILITY(U,$J,358.3,22047,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,22047,1,2,0)
 ;;=2^INTRADERMALS (EACH)
 ;;^UTILITY(U,$J,358.3,22047,1,3,0)
 ;;=3^95024
 ;;^UTILITY(U,$J,358.3,22048,0)
 ;;=86510^^124^1384^2^^^^1
 ;;^UTILITY(U,$J,358.3,22048,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,22048,1,2,0)
 ;;=2^HISTOPLASMOSIS
 ;;^UTILITY(U,$J,358.3,22048,1,3,0)
 ;;=3^86510
 ;;^UTILITY(U,$J,358.3,22049,0)
 ;;=99395^^124^1385^1^^^^1
 ;;^UTILITY(U,$J,358.3,22049,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,22049,1,2,0)
 ;;=2^PREVENTIVE MED,EST PT 18-39
 ;;^UTILITY(U,$J,358.3,22049,1,3,0)
 ;;=3^99395
 ;;^UTILITY(U,$J,358.3,22050,0)
 ;;=99396^^124^1385^2^^^^1
 ;;^UTILITY(U,$J,358.3,22050,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,22050,1,2,0)
 ;;=2^PREVENTIVE MED,EST PT 40-64
 ;;^UTILITY(U,$J,358.3,22050,1,3,0)
 ;;=3^99396
 ;;^UTILITY(U,$J,358.3,22051,0)
 ;;=99397^^124^1385^3^^^^1
 ;;^UTILITY(U,$J,358.3,22051,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,22051,1,2,0)
 ;;=2^PREVENTIVE MED,EST PT > 64
 ;;^UTILITY(U,$J,358.3,22051,1,3,0)
 ;;=3^99397
 ;;^UTILITY(U,$J,358.3,22052,0)
 ;;=99385^^124^1386^1^^^^1
 ;;^UTILITY(U,$J,358.3,22052,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,22052,1,2,0)
 ;;=2^PREVENTIVE MED,NEW PT 18-39
 ;;^UTILITY(U,$J,358.3,22052,1,3,0)
 ;;=3^99385
 ;;^UTILITY(U,$J,358.3,22053,0)
 ;;=99386^^124^1386^2^^^^1
 ;;^UTILITY(U,$J,358.3,22053,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,22053,1,2,0)
 ;;=2^PREVENTIVE MED,NEW PT 40-64
 ;;^UTILITY(U,$J,358.3,22053,1,3,0)
 ;;=3^99386
 ;;^UTILITY(U,$J,358.3,22054,0)
 ;;=99387^^124^1386^3^^^^1
 ;;^UTILITY(U,$J,358.3,22054,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,22054,1,2,0)
 ;;=2^PREVENTIVE MED,NEW PT > 64
 ;;^UTILITY(U,$J,358.3,22054,1,3,0)
 ;;=3^99387
 ;;
 ;;$END ROU IBDEI18U
